EDAP TMS SA Secures 36M Euro Credit Facility for Growth

TL;DR

EDAP TMS SA lands 36M Euro credit line to fuel Focal One growth!

AI Summary

EDAP TMS SA announced on August 26, 2025, a Letter of Intent for a 36 million Euro credit facility. This funding is intended to accelerate the company's growth and strategic expansion, specifically supporting the continued development and commercialization of its Focal One® Robotic HIFU technology.

Why It Matters

This significant credit facility provides EDAP TMS SA with the financial resources to expand its operations and further develop its innovative Focal One® technology, potentially impacting its market position and future revenue streams.

Risk Assessment

Risk Level: medium — The company is seeking debt financing, which introduces financial leverage and repayment obligations, and the success of the funding is contingent on finalizing the agreement.

Key Numbers

• €36M — Credit Facility (Amount intended to accelerate growth and strategic expansion)

Key Players & Entities

• EDAP TMS SA (company) — Filer of the report and recipient of the credit facility
• 36 million Euro (dollar_amount) — Amount of the credit facility
• August 26, 2025 (date) — Date of the announcement and filing
• Focal One® Robotic HIFU (product) — Technology to be supported by the credit facility
• KEN MOBECK (person) — Chief Financial Officer who signed the report

FAQ

Filing Documents

• f6k_082625.htm (6-K) — 13KB
• 0001171843-25-005588.txt ( ) — 14KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 26, 2025 EDAP TMS S.A. /s/ KEN MOBECK KEN MOBECK CHIEF FINANCIAL OFFICER EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion Funding to Support Continued Growth of Focal One ® Robotic HIFU AUSTIN, Texas, August 26, 2025 - EDAP TMS SA (Nasdaq: EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, today announced execution of a letter of intent for EUR 36 million credit facility with the European Investment Bank (EIB). Proceeds from this financing will support the continued expansion of Focal One ® Robotic HIFU in Focal Therapy, the fastest-growing treatment category for early-stage prostate cancer while accelerating the development of new clinical indications. Pending the signature of the final legal documents, the Credit Facility is expected to close no later than the end of Calendar Year 2025. "We are pleased to announce this agreement on a letter of intent for such an important and strategic financing facility with the European Investment Bank," said Ryan Rhodes, Chief Executive Officer of EDAP. "The capital raised through this financing immediately enhances our balance sheet, offering a substantial source of low-interest funding that we can access in tranches as needed." Over the last several years, the EIB has been an extraordinary partner in helping companies deliver new and promising innovative technologies for the benefit of millions of patients across the globe. I would like to thank the EIB for their support, as we believe this additional capital will enable more physicians and their patients to access the benefits of Focal One Robotic HIFU." About EDAP TMS SA A recognized leader in robotic energy-based therapies, EDAP TMS develops, m

Forward-Looking Statements

Forward-Looking Statements In addition to historical information, this press release contains forward-looking statements within the meaning of applicable federal securities laws, including Section 27A of the U.S. Securities Act of 1933 (the "Securities Act") or Section 21E of the U.S. Securities Exchange Act of 1934, which may be identified by words such as "believe," "can," "contemplate," "could," "plan," "intend," "is designed to," "may," "might," "potential," "objective," "target," "project," "predict," "forecast," "ambition," "guideline," "should," "will," "estimate," "expect" and "anticipate," or the negative of these and similar expressions, which reflect our views about future events and financial performance. Such statements include our expectations to enter into a credit facility with EIB, the size thereof, the timing thereof and the use of proceeds from such credit facility. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking our lithotripsy and distribution divisions, as well as risks associated with the current worldwide inflationary environment, the uncertain worldwide economic, political and financial environment, geopolitical instability, climate change and pandemics like the COVID 19 pandemic, or other public health crises, and their related impact on our business operations, including their impacts across our businesses or demand for our devices and services. Other factors that may cause such a difference may also include, but

Forward-looking statements speak only as of the

Forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information or future developments. These forward-looking statements are based upon information, assumptions and estimates available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete. Company Contact Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 50 bconfort@edap-tms.com Investor Contact John Fraunces LifeSci Advisors, LLC (917) 355-2395 jfraunces@lifesciadvisors.com

View Full Filing

View this 6-K filing on SEC EDGAR